[Concomitant surgical treatment of valvular heart disease and coronary artery disease]

T Sakurada1, Y Kikuchi, T Suzuki

  • 1Department of Cardiovascular Surgery, National Obihiro Hospital, Japan.

Insights

Concomitant aortic valve replacement and coronary artery bypass grafting showed good outcomes. However, combined mitral valve surgery and coronary artery bypass grafting may require improved surgical strategies for better results.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Coronary Artery Disease Management

Context:

  • 24 patients underwent combined valvular surgery and coronary artery bypass grafting.
  • Aortic valve replacement (AVR) was performed in 18 patients (Group A).
  • Mitral valve surgery (MVS) was performed in 6 patients (Group M).

Purpose:

  • To evaluate the outcomes of concomitant aortic and mitral valve surgery with coronary artery bypass grafting.
  • To compare the results between aortic and mitral valve procedures in combination with coronary revascularization.

Summary:

  • Group A (AVR + CABG) had 2 hospital deaths (11.1%) with satisfactory outcomes.
  • Group M (MVS + CABG) had 2 hospital deaths (33.3%) including one late death, suggesting a need for improved surgical management.
  • Mitral valve replacement with Hancock II in Group M was associated with higher mortality.

Impact:

  • Aortic valve replacement combined with coronary revascularization is a viable procedure.
  • Current surgical approaches for concomitant mitral valve disease and coronary artery disease may need refinement.
  • Further research is warranted to optimize outcomes for combined mitral valve and coronary artery bypass grafting.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...